Wolfgang Weber, MD, presented “Molecular Imaging of Prostate Cancer” during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019 in Boston, Massachusetts.

How to cite: Weber, Wolfgang. “Molecular Imaging of Prostate Cancer” October 3, 2019. Accessed Apr 2020. https://grandroundsinurology.com/molecular-imaging-of-prostate-cancer/

Molecular Imaging of Prostate Cancer – Summary:

Wolfgang Weber, MD, Professor and Chair of the Department of Nuclear Medicine at the Technical University of Munich in Germany, discusses the changes in molecular imaging over the last 7 years and their impact on staging and re-staging of prostate cancer. Dr. Weber discusses how PSMA PET imaging works by binding with the ligands of antigens present in cells affected by prostate cancer. He also describes studies in which molecular imaging has been useful in reclassifying nmCRPC by identifying metastases not visible using conventional imaging, specifically in bones and lymph nodes. This has led to novel theranostic approaches where imaging closely intertwines with surgery or chemotherapy to potentially improve treatment outcomes.

About The 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer:

The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a multi-day, multi-disciplinary forum designated to inform health care stakeholders about topics including in-vitro fluid- and tissue-based molecular diagnostics, novel observation strategies such as active surveillance, and novel therapeutic interventions. Along with this forum’s efforts to form a consensus on the future of prostate diagnostics and precision care, it aims to create an educational and research strategy for its realization. Dr. Weber presented this lecture during the 4th iteration of this summit in 2019.